Percutaneous endoscopic gastrostomy - indication and course

• Conditions: E46; Unspecified protein-energy malnutrition

• Registration Number: DRKS00005061
• Lead Sponsor: Medizinische Hochschule Hannover

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-09-26
• Study Start: 2013-06-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 119

Inclusion Criteria

Indication for PEG, written informed consent.

Exclusion Criteria

A life expectancy of less than 14 days, pregnancy or breast feeding, severe coagulation disorders, and ascites in the upper abdomen. Denial of consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival (4 weeks)

Secondary Outcome Measures

Name	Time	Method
Complications after PEG placement at discharge, and during the follow-up after 4,12, and 24 weeks. Survival after 6 months.